Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000919574-18-002505
Filing Date
2018-03-15
Accepted
2018-03-15 16:19:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7843807_13d-a.htm SC 13D/A 95784
  Complete submission text file 0000919574-18-002505.txt   97207
Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2463
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Subject) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88042 | Film No.: 18692637
SIC: 2834 Pharmaceutical Preparations